/PRNewswire/ Mileutis, an Israeli-based biopharmaceutical company revolutionizing how farmers and veterinarians treat a range of diseases, today announced.
MinervaX provides clinical and leadership update Completed enrolment of 150 pregnant women in a Phase 2 study in South Africa and dosing started in an additional 50 pregnant women in Uganda, as part of same study Phase 1 booster study started in the United Kingdom Regulatory approval obtained from Danish Medicines A.
Shareholders approved all resolutions Gosselies, Belgium, 10 June 2021, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces the results of its Annual General Meeting held on Wednesday 9 June 2021 at 4pm CEST. Shareholders approved all items on the agenda of the annual shareholders' meeting including the renewal of the mandates of Jean Stéphenne and Jean-Paul Prieels as non-ex